Related Experiment Video
Updated: Jun 13, 2026

06:19
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
[Multiple sclerosis as a polygenic disease: an update].
Genetika
|April 16, 2010
Summary
Multiple sclerosis (MS) is a polygenic disease influenced by multiple genes. Recent advances, including genome-wide association screening (GWAS), identify genetic factors contributing to MS susceptibility.
Area of Science:
- Neuroimmunology
- Genetics
- Epidemiology
Context:
- Multiple sclerosis (MS) is a chronic inflammatory central nervous system disease.
- MS exhibits a polygenic inheritance pattern, suggesting contributions from multiple genes.
- Understanding the genetic basis of MS is crucial for disease management and research.
Purpose:
- To review validated genetic findings for multiple sclerosis (MS).
- To describe the application of candidate gene analysis, linkage studies, and genome-wide association screening (GWAS) in MS research.
- To present data on MS associations with individual genes and allelic combinations.
Summary:
- This review consolidates findings from candidate gene studies, linkage analyses, and genome-wide association screening (GWAS) for multiple sclerosis (MS).
- It details validated genetic loci and genes implicated in MS predisposition across various chromosomes.
- The review also covers associations between MS and combined effects of multiple gene alleles.
Impact:
- Provides a comprehensive overview of the genetic architecture of multiple sclerosis.
- Highlights the evolution and utility of different genetic research strategies in identifying MS susceptibility genes.
- Informs future research directions for understanding MS pathogenesis and developing targeted therapies.
Related Concept Videos
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Polygenic Traits
When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
Polygenic Traits
When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Autoimmune Disorders
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Concept and Mechanism of Autoimmune Diseases
The immune system...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
